Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 439-443

  Theunissen, Eef L ^a   Elvira, Javier De La Asuncion ^a   Van Den Bergh, Dries ^a   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Fexofenadine; Methylphenidate; Modafinil; Psychomotor performance; Psychostimulant

Indexed keywords

FEXOFENADINE; METHYLPHENIDATE; MODAFINIL; PLACEBO;

ALERTNESS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TASK PERFORMANCE;

ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; METHYLPHENIDATE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TERFENADINE; YOUNG ADULT;

EID: 70349695834     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b3b5f3     Document Type: Article

References (42)

1. Tashiro M, Mochizuki H, Iwabuchi K, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002;72:409-414.
2. Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000;105:S622YS627.
3. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-1994. Allergy. 1995;50:234-342.
4. Rombaut NEI, Hindmarch I. Psychometric aspects of antihistamines: A review. Hum Psychopharmacol. 1994;9:157-169.
5. Simons FE. H1-receptor antagonists. Comparative tolerability and safety. Drug Saf. 1994;10:350-380.
6. Passalacqua G, Bousquet J, Bachert C, et al. The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy. 1996;51:666-675.
7. Bender BG, Berning S, Dudden R, et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis. J Allergy Clin Immunol. 2003;111:770-776.
8. Vermeeren A, O'Hanlon JF. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol. 1998;101:306-311.
9. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132:354-363.
10. Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy. 1999;29:133-142.
11. Nicholson AN, Stone BM, Turner C, et al. Antihistamines and aircrew: usefulness of fexofenadine. Aviat Space Environ Med. 2000;71:2-6.
12. Bower EA, Moore JL, Moss M, et al. The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviat Space Environ Med. 2003;74:145-152.
13. Vuurman EFPM, Rikken GH, Muntjewerff ND, et al. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol. 2004;60:307-313.
14. Moskowitz H, Burns MB. Effects of terfenadine, diphenhydramine, and placebo on skills performance. Cutis. 1988;42:14-18.
15. Clarke CH, Nicholson AN. Performance studies with antihistamines. Br J Clin Pharmacol. 1978;6:31-35.
16. Reinberg A, Levi F, Guillet P, et al. Chronopharmacological study of antihistamines in man with special to terfenadine. Eur J Clin Pharmacol. 1978;14:245-252.
17. Mattila MJ, Kuitunen T, Pletan Y. Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol. 1992;43:179-184.
18. Elliott R, Sahakian BJ, Matthews K, et al. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl). 1997;131:196-206.
19. Leonard BE, McCartan D, White J, et al. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol. 2004;19:151-180.
20. Boutrel B, Koob GF. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep. 2004;27:1181-1194.
21. Turner DC, Robbins TW, Clark L, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl). 2003;165:260-269.
22. Randall DC, Viswanath A, Bharania P, et al. Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol. 2005;25:175-179.
23. Saper CB, Scammell TE. Modafinil: a drug in search of a mechanism. Sleep. 2004;27:11-12.
24. Theunissen EL, Vermeeren A, Vuurman EFPM, et al. Stimulating effects of H1-antagonists. Curr Pharm Des. 2006;12:2501-2509.
25. Jex HR, McDonnell JD, Phatak AV. A Bcritical[ tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR. 1966;1-105.
26. Moskowitz H. Laboratory studies of the effects of alcohol on some variables related to driving. J Safety Res. 1973;5:185-192.
27. Mackworth NH. Researches on the measurement of human performance. In: Sinaiko HW, ed. Selected Papers on Human Factors in the Design and Use of Control Systems. New York, NY: Dover; 1950:174-331.
28. Fillmore MT, Rush CR, Hays L. Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend. 2002; 67:157-167.
29. Ramaekers JG, Kauert G, van Ruitenbeek P, et al. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 2006;31:2296-2303.
30. Ramaekers JG, Kuypers KPC. Acute effects of 3,4- methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. Neuropsychopharmacology. 2006;31:1048-1055.
31. Logan GD. On the ability to inhibit thought and action. In: Dagenbach D, Carr TH, eds. Inhibitory Processes in Attention, Memory and Language. San Diego, Calif: Academic Press; 1994:189-239.
32. Wesensten NJ. Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des. 2006;12: 2457-2471.
33. Theunissen EL, van Kroonenburgh MJ, van Deursen JA, et al. Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis. Psychopharmacology (Berl). 2006;187:95-102.
34. Theunissen EL, Jonkman LM, Kuypers KPC, et al. Stimulating effects of fexofenadine under high workload conditions. A combined neurophysiological and behavioral approach. J Psychopharmacol (Oxf ). 2006;20:485-495.
35. de Wit H, Enggasser JL, Richards JB. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology. 2002;27:813-825.
36. Fillmore MT, Rush CR, Marczinski CA. Effects of D-amphetamine on behavioral control in stimulant abusers: he role of prepotent response tendencies. Drug Alcohol Depend. 2003;71:143-152.
37. Randall DC, Fleck NL, Shneerson JM, et al. The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav. 2004;77: 547-555.
38. Randall DC, Shneerson JM, File SE. Cognitive effects of modafinil in student volunteers may depend on iq. Pharmacol Biochem Behav. 2005;82:133-139.
39. Mehta MA, Goodyer IM, Sahakian BJ. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry. 2004;45:293-305.
40. Naylor H, Halliday R, Callaway E. The effect of methylphenidate on information processing. Psychopharmacology (Berl). 1985;86:90-95.
41. Camp Bruno JA, Herting RL. Cognitive effects of milacemide and methylphenidate in healthy young adults. Psychopharmacology (Berl). 1994;115:46-52.
42. Mehta MA, Owen AM, Sahakian BJ, et al. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci. 2000;20:Rc65.